| Stocks Gallery | Interpace Diagnostics to Host Conference Call and Webcast to Discuss Second Quarter 2017 Financial Results on ... GlobeNewswire (press release) The Company currently has three commercialized molecular tests: PancraGEN®, for the evaluation of pancreatic cysts and assessment of risk of concomitant or subsequent cancer; ThyGenX®, for the diagnosis of thyroid cancer from thyroid nodules utilizing ... Lsv Asset Management Lowered By $7.38 Million Its Hca Holdings (HCA) Position; Interpace Diagnostics Group (IDXG ...San Times all 7 news articles » |
from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2hLGklL
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,